The €6.2 billion ($6.7 billion) sale of Bombardier's rail business will close next year, the €17.2 billion deal for Thyssenkrupp’s elevator division will require a debt package, and a drugmaker working on a COVID-19 vaccine is planning a July IPO. Here, Law360 breaks down these and other deal rumors from the past week that you need to be aware of.